<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308279">
  <stage>Registered</stage>
  <submitdate>23/07/2009</submitdate>
  <approvaldate>27/07/2009</approvaldate>
  <actrnumber>ACTRN12609000624280</actrnumber>
  <trial_identification>
    <studytitle>Pilot study of the effects of low salt intake on obstructive sleep apnoea</studytitle>
    <scientifictitle>In moderate-severe untreated obstructive sleep apnoea (OSA) patients who have a high sodium intake, does a 7-day low-sodium diet reduce apnoea-hypopnoea index</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive sleep apnoea</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Low sodium diet (&lt; 50 mmol/day) for 7 days</interventions>
    <comparator>None</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction in apnoea-hypopnoea index</outcome>
      <timepoint>7th day of the low-sodium diet</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Neck circumference</outcome>
      <timepoint>7th day of the low-sodium diet</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Weight change as measured using laboratory scale.</outcome>
      <timepoint>7th day of the low-sodium diet</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood pressure as measured using a manual technique with an aneroid sphygmomanometer.</outcome>
      <timepoint>7th day of the low-sodium diet</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Apnoea-hypopnoea index &gt;=15
20 &lt; Body mass index (BMI) &lt; 30 kg/m2. 
Baseline 24 hour urine sodium excretion &gt;= 200 mmol/day.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Continuous Positive Airway Pressure (CPAP) or other treatment for OSA.
Anatomical features known to cause OSA.
Office Blood Pressure (BP) &lt; 100/60 mm Hg at baseline.
Current treatment for hypertension.
Diabetes.
Pathology that might cause fluid retention</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Woolcock Institute of Medical Research</primarysponsorname>
    <primarysponsoraddress>431 Glebe Point Road
Glebe NSW 2037</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Martin Turner</fundingname>
      <fundingaddress>Woolcock Institute of Medical Research
431 Glebe Point Road
Glebe NSW 2037</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to find out if high salt intake contributes to the severity of obstructive sleep apnoea. Our hypothesis is that reduction of salt intake in people with moderate to severe sleep apnoea will reduce the symptoms of the sleep apnoea.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney South West Area Health Service Human Research Ethics Committee (HREC)</ethicname>
      <ethicaddress>Royal Prince Alfred Hospital
Missenden Road
Camperdown
NSW 2050</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>29/07/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Martin Turner</name>
      <address>Woolcock Institute of Medical Research
PO Box M77
Missenden Road
Camperdown
NSW 2050</address>
      <phone>+61 2 9114 0419</phone>
      <fax />
      <email>mjturner@usyd.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Martin Turner</name>
      <address>Woolcock Institute of Medical Research
PO Box M77
Missenden Road
Camperdown
NSW 2050</address>
      <phone>+61 2 9114 0419</phone>
      <fax />
      <email>mjturner@usyd.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Martin Turner</name>
      <address>Woolcock Institute of Medical Research
PO Box M77
Missenden Road
Camperdown
NSW 2050</address>
      <phone>+61 2 9114 0419</phone>
      <fax />
      <email>mjturner@usyd.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>